Avita Medical | 1811094D - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Accuray USD 41.29M 22.05M 2025-12
Celltrion KRW 56.79B 6.92B 2026-03
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Cochlear AUD 275.7M 107.4M 2025-06
CSL USD 2.16B 633M 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Kangmei Pharma CNY 1.23B 48.16M 2026-03
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Mayne Pharma AUD 110.07M 838K 2024-06
Medical Developments International AUD 17.84M 219K 2025-06
Nanosonics AUD 161.29M 156.45M 2025-06
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organigram Holdings CAD 4.29M 3.28M 2026-03
Pacific Edge NZD 29.26M 8.79M 2024-06
Paradigm Biopharmaceuticals AUD 16.82M 1M 2025-06
Pharma Mar EUR 48.86M 31.05M 2026-03
Polynovo AUD 29.21M 16.7M 2025-12
PYC Therapeutics AUD 153.05M 103.8M 2025-06
Qiagen NV USD 646.29M 192.72M 2026-03
Ramsay Health Care AUD 784.4M 443.3M 2025-06
ResMed USD 1.66B 243.44M 2026-03
Sartorius EUR 291M 282.8M 2026-06
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Telix Pharmaceuticals AUD 207.16M 503.19M 2025-06
Tilray USD 264.83M 43.16M 2025-06
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.96B 186.63M 2026-03